Authors:
Wight, NJ
Gottesdiener, K
Garlick, NM
Atherton, CT
Novak, S
Gertz, BJ
Calder, NA
Cote, J
Wong, P
Dallob, A
Hawkey, CJ
Citation: Nj. Wight et al., Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production, GASTROENTY, 120(4), 2001, pp. 867-873